Hanping Feng, Ph.D.

Affiliations: 
2002 University of Arizona, Tucson, AZ 
Area:
Immunology, Oncology, Microbiology Biology
Google:
"Hanping Feng"

Parents

Sign in to add mentor
Emmanuel Katsanis grad student 2002 University of Arizona
 (Immunological consequences of apoptosis in a tumor system.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wang J, Ortiz C, Fontenot L, et al. (2019) The therapeutic mechanism macrophage inflammatory protein 1 alpha (MIP-1α/CCL3) neutralizing antibody in Clostridium difficile infection in mice. The Journal of Infectious Diseases
Chen P, Lam KH, Liu Z, et al. (2019) Structure of the full-length Clostridium difficile toxin B. Nature Structural & Molecular Biology
Simeon R, Jiang M, Chamoun-Emanuelli AM, et al. (2019) Selection and characterization of ultrahigh potency designed ankyrin repeat protein inhibitors of C. difficile toxin B. Plos Biology. 17: e3000311
Tam J, Hamza T, Ma B, et al. (2018) Host-targeted niclosamide inhibits C. difficile virulence and prevents disease in mice without disrupting the gut microbiota. Nature Communications. 9: 5233
Zhang Y, Li S, Yang Z, et al. (2018) Cysteine Protease-Mediated Autocleavage of Toxins Regulates Their Proinflammatory Activity. Cellular and Molecular Gastroenterology and Hepatology. 5: 611-625
Zhang Y, Yang Z, Gao S, et al. (2017) The role of purified Clostridium difficile glucosylating toxins in disease pathogenesis utilizing a murine cecum injection model. Anaerobe
Chen S, Wang H, Gu H, et al. (2016) Identification of an Essential Region for Translocation of Clostridium difficile Toxin B. Toxins. 8
Yang Z, Shi L, Yu H, et al. (2016) Intravenous adenovirus expressing a multi-specific, single-domain antibody neutralizing TcdA and TcdB protects mice from Clostridium difficile infection. Pathogens and Disease
Maldarelli GA, Matz H, Gao S, et al. (2016) Pilin Vaccination Stimulates Weak Antibody Responses and Provides No Protection in a C57Bl/6 Murine Model of Acute Clostridium difficile Infection. Journal of Vaccines & Vaccination. 7
Mehta KK, Paskaleva EE, Wu X, et al. (2016) Newly identified bacteriolytic enzymes that target a wide range of clinical isolates of Clostridium difficile. Biotechnology and Bioengineering
See more...